Michael F Maclean
Chief Financial Officer; Director · 3 filings · Latest: Apr 1, 2026
Avidity Biosciences, Inc.
Camp4 Therapeutics Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
RNA | Michael F Maclean | Chief Financial Officer | Jan 21, 2026 | Sale | $72.45 | 4,542 | $329.1K | 59,290 | |
RNA | MICHAEL MACLEAN | — | Aug 6, 2025 | Proposed Sale | $38.26 | 30,914 | $1.2M | — | |
RNA | MICHAEL MACLEAN | — | Nov 6, 2024 | Proposed Sale | $45.09 | 106,319 | $4.8M | — | |